Drug Approval | April 22, 2026
US FDA okays Merck's new once-daily HIV pill
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
By cutting pain crises & boosting haemoglobin
A decision is expected by August 17, 2026 under the Prescription Drug User Fee Act timeline
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
Manoj has over two decades of experience in healthcare operations and biomedical engineering
The programme integrates simulation-based training, expert-led sessions, and case-based discussions
The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
The cleanroom operates under stringent ISO Class 5 conditions, using ultrapure water and air systems
The conclave brought together key stakeholders from across the assisted living ecosystem
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
Subscribe To Our Newsletter & Stay Updated
